Clinical trials
Phase 3 Hemorrhage trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| Population Health Research Institute | 2 |
| Shanghai Jiao Tong University School of Medicine | 2 |
| Takeda | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Chinese University of Hong Kong | 1 |
| Eye & ENT Hospital of Fudan University | 1 |
| Idorsia Pharmaceuticals Ltd. | 1 |
| Medprin Regenerative Medical Technologies Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 17 |
| Autoimmune Diseases | 2 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Hematologic Diseases | 2 |
| Hemophilia A | 2 |
| Hemophilia B | 2 |
| Hemorrhagic Disorders | 2 |
| Immune System Diseases | 2 |
| Purpura | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.